231 related articles for article (PubMed ID: 20888407)
21. Comparison of the oxime-induced reactivation of rhesus monkey, swine and guinea pig erythrocyte acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity.
Herkert NM; Lallement G; Clarençon D; Thiermann H; Worek F
Toxicology; 2009 Apr; 258(2-3):79-83. PubMed ID: 19428926
[TBL] [Abstract][Full Text] [Related]
22. Acetylcholinesterase inhibition: does it explain the toxicity of organophosphorus compounds?
Maxwell DM; Brecht KM; Koplovitz I; Sweeney RE
Arch Toxicol; 2006 Nov; 80(11):756-60. PubMed ID: 16770629
[TBL] [Abstract][Full Text] [Related]
23. In vitro inhibitory effect of aflatoxin B1 on acetylcholinesterase activity in mouse brain.
Cometa MF; Lorenzini P; Fortuna S; Volpe MT; Meneguz A; Palmery M
Toxicology; 2005 Jan; 206(1):125-35. PubMed ID: 15590113
[TBL] [Abstract][Full Text] [Related]
24. Metoclopramide protection of cholinesterase from paraoxon inhibition.
Petroianu GA; Hasan MY; Kosanovic M; Vijayasarathy C; Saleh AM
Vet Hum Toxicol; 2003 Oct; 45(5):251-3. PubMed ID: 14513894
[TBL] [Abstract][Full Text] [Related]
25. Distribution of SH-SY5Y human neuroblastoma cells in the cell cycle following exposure to organophosphorus compounds.
Carlson K; Ehrich M
J Biochem Mol Toxicol; 2008; 22(3):187-201. PubMed ID: 18561334
[TBL] [Abstract][Full Text] [Related]
26. Monoquaternary pyridinium salts with modified side chain-synthesis and evaluation on model of tabun- and paraoxon-inhibited acetylcholinesterase.
Musilek K; Kucera J; Jun D; Dohnal V; Opletalova V; Kuca K
Bioorg Med Chem; 2008 Sep; 16(17):8218-23. PubMed ID: 18676153
[TBL] [Abstract][Full Text] [Related]
27. In vitro oxime-assisted reactivation of paraoxon-inhibited human acetylcholinesterase and butyrylcholinesterase.
Musilova L; Kuca K; Jung YS; Jun D
Clin Toxicol (Phila); 2009 Jul; 47(6):545-50. PubMed ID: 19586353
[TBL] [Abstract][Full Text] [Related]
28. In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate.
Lorke DE; Hasan MY; Arafat K; Kuca K; Musilek K; Schmitt A; Petroianu GA
J Appl Toxicol; 2008 May; 28(4):422-9. PubMed ID: 18344198
[TBL] [Abstract][Full Text] [Related]
29. Minireview: does in-vitro testing of oximes help predict their in-vivo action after paraoxon exposure?
Lorke DE; Petroianu GA
J Appl Toxicol; 2009 Aug; 29(6):459-69. PubMed ID: 19603416
[TBL] [Abstract][Full Text] [Related]
30. An alternative in vitro method for detecting neuropathic compounds based on acetylcholinesterase inhibition and on inhibition and aging of neuropathy target esterase (NTE).
Sogorb MA; González-González I; Pamies D; Vilanova E
Toxicol In Vitro; 2010 Apr; 24(3):942-52. PubMed ID: 20097283
[TBL] [Abstract][Full Text] [Related]
31. Effects of polyhydroxyfullerenes on organophosphate-induced toxicity in mice.
Ehrich M; Hinckley J; Werre SR; Zhou Z
Toxicology; 2020 Dec; 445():152586. PubMed ID: 32949634
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of novel analogues of vitamin B6 as reactivators of tabun and paraoxon inhibited acetylcholinesterase.
Gaso-Sokac D; Katalinić M; Kovarik Z; Busić V; Kovac S
Chem Biol Interact; 2010 Sep; 187(1-3):234-7. PubMed ID: 20144593
[TBL] [Abstract][Full Text] [Related]
33. [A comparison of the efficacy of the reactivators of acetylcholinesterase inhibited with tabun].
Cabal J; Kuca K; Jun D; Bajgar J; Hrabinová M
Ceska Slov Farm; 2005 Jul; 54(4):192-5. PubMed ID: 16124202
[TBL] [Abstract][Full Text] [Related]
34. Degradation of organophosphorus neurotoxicity in SY5Y neuroblastoma cells by organophosphorus hydrolase (OPH).
Cho TM; Wild JR; Donnelly KC; Tiffany-Castiglioni E
J Toxicol Environ Health A; 2006 Aug; 69(15):1413-29. PubMed ID: 16766477
[TBL] [Abstract][Full Text] [Related]
35. The readthrough variant of acetylcholinesterase remains very minor after heat shock, organophosphate inhibition and stress, in cell culture and in vivo.
Perrier NA; Salani M; Falasca C; Bon S; Augusti-Tocco G; Massoulié J
J Neurochem; 2005 Aug; 94(3):629-38. PubMed ID: 16001972
[TBL] [Abstract][Full Text] [Related]
36. Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate esters.
Gearhart JM; Jepson GW; Clewell HJ; Andersen ME; Conolly RB
Environ Health Perspect; 1994 Dec; 102 Suppl 11(Suppl 11):51-60. PubMed ID: 7737042
[TBL] [Abstract][Full Text] [Related]
37. Protective effect of C(60) -methionine derivate on lead-exposed human SH-SY5Y neuroblastoma cells.
Chen T; Li YY; Zhang JL; Xu B; Lin Y; Wang CX; Guan WC; Wang YJ; Xu SQ
J Appl Toxicol; 2011 Apr; 31(3):255-61. PubMed ID: 20878908
[TBL] [Abstract][Full Text] [Related]
38. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon.
Petroianu GA; Arafat K; Kuca K; Kassa J
J Appl Toxicol; 2006; 26(1):64-71. PubMed ID: 16193529
[TBL] [Abstract][Full Text] [Related]
39. Bisquaternary oximes as reactivators of tabun-inhibited human brain cholinesterases: an in vitro study.
Kuca K; Jun D; Cabal J; Musilova L
Basic Clin Pharmacol Toxicol; 2007 Jul; 101(1):25-8. PubMed ID: 17577312
[TBL] [Abstract][Full Text] [Related]
40. In vivo metoclopramide protection of cholinesterase from paraoxon inhibition: direct comparison with pralidoxime in subchronic low-dose exposure.
Hasan MY; Nurulain SM; Arafat K; Naseer OP; Petroianu GA
J Appl Toxicol; 2004; 24(4):257-60. PubMed ID: 15300712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
